Peptide safety concerns: what the evidence actually shows

What did @gabeswen_md actually say?

The doctor's core argument is simple: MT2 stimulates melanocytes, melanocytes gone wrong become melanoma, and "there is no data showing that it is safe." He's not claiming MT2 causes cancer outright. He's saying the absence of safety data, combined with reports of rapid mole eruptions, makes it a risk he personally won't take. He used graphic images of metastatic melanoma to put a face on the worst-case scenario. That framing matters when you evaluate whether his argument holds up.

He described people injecting MT2 at home after finding discount codes in TikTok bios, and he called that "inconceivable." Fair enough. MT2 is not FDA-approved for any use in humans. It is sold online under labels like "research chemical" or "for laboratory use only," which is a legal workaround that does not make it safe or regulated.

Does the science back this up?

Mostly, yes, though the picture is more specific than the video suggests. MT2 (melanotan II) is a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH) that activates melanocortin receptors, particularly MC1R and MC4R. Activating MC1R drives melanin production and darkens the skin. That mechanism is real and well-characterized.

The concern about moles is also grounded in biology. Case reports in the literature document existing nevi changing and new nevi appearing after MT2 use. A 2014 case series by Coelho et al. in the British Journal of Dermatology documented dermoscopic changes in melanocytic nevi in patients using MT2, with some lesions developing features requiring biopsy. A 2009 paper by Bliss et al. in Clinical and Experimental Dermatology reported a case of nodular melanoma arising after MT2 use, though causation could not be established. The mechanistic concern is plausible: pushing melanocytes to overproduce pigment in people with pre-existing atypical nevi or genetic risk is not obviously safe.

However, there is currently no randomized controlled trial or large cohort study establishing a causal link between MT2 and melanoma. The creator is accurate when he says "there is no data necessarily linking MT2 with melanoma." That's the honest scientific position right now.

What did they get wrong (or right)?

He got the core precautionary logic right. MT2 has no completed Phase III human safety trials. Saying "not proven safe" is accurate. That's not a high bar to clear, but a lot of peptide promoters on TikTok pretend that bar doesn't exist, so credit where it's due.

Where the video gets softer is in the implied causation. Showing images of metastatic melanoma lung mets and brain mets immediately after talking about MT2 creates a visual association that goes beyond what the data currently supports. Viewers will connect those images to MT2 use even though the creator explicitly says the link is not proven. That's a rhetorical move, not a scientific one. Emotional framing can be a legitimate tool in public health communication, but it should be labeled as such rather than embedded in a fact-based argument.

He also doesn't mention that MT2 was actually investigated in clinical trials by Competitive Technologies and Palatin Technologies in the 1990s and early 2000s for erectile dysfunction and female sexual dysfunction, and those trials were discontinued, partly over safety concerns including nausea, facial flushing, and spontaneous erections, but not because of a demonstrated cancer signal. That context would have made the argument more precise.

What should you actually know?

The honest summary is this: MT2 is a pharmacologically active compound with real effects on melanocytes. It has not been tested adequately for long-term human safety. Anecdotal reports of rapid nevus changes after use are biologically plausible and documented in case reports. No large-scale study has established a causal link between MT2 and melanoma, but the absence of that evidence is not the same as evidence of absence.

Anyone with a personal or family history of melanoma, atypical nevus syndrome, or fair skin with a high baseline mole count should treat this as a meaningful risk signal, not a theoretical one. The underground market for MT2 also means there is no quality control, no confirmed dosing accuracy, and no sterility guarantee on vials being injected at home.

• MT2 is not FDA-approved for any human indication.
• Case reports exist documenting nevus changes after use (Coelho et al., 2014, British Journal of Dermatology).
• The mechanism that makes skin tan is the same one that, dysregulated, contributes to melanoma development.
• Buying injectable compounds from TikTok bio links means you have no idea what is actually in the vial.